Pubblicazioni

Immune checkpoint modulators in early clinical development for the treatment of type 1 diabetes

2024 - EXPERT OPINION ON INVESTIGATIONAL DRUGS
Maddaloni, Ernesto; Amendolara, Rocco; Balena, Angela; Latino, Alessandro; Sessa, Rosario Luigi; Buzzetti, Raffaella

Investigational therapies targeting CD3 for prevention and treatment of type 1 diabetes

2021 - EXPERT OPINION ON INVESTIGATIONAL DRUGS
Mignogna, C.; Maddaloni, E.; D'Onofrio, L.; Buzzetti, R.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma